Department of Clinical Analysis, School of Pharmacy, University of São Paulo, São Paulo, Brazil.
Department of Internal Medicine, School of Veterinary Medicine and Animal Science, University of São Paulo, São Paulo, Brazil.
Microb Drug Resist. 2023 Jul;29(7):296-301. doi: 10.1089/mdr.2022.0249. Epub 2023 May 4.
The global dissemination of extended-spectrum-β-lactamase (ESBL)-producing has been considered a critical issue within a One Health framework. The aim of this study was to perform a genomic investigation of an ESBL-producing strain belonging to the globally spread sequence type/clonal complex ST90/CC23, isolated from gastrointestinal tract of a dog, in Brazil. Besides CTX-M-15 ESBL, this isolate carried mutations conferring resistance to human and veterinary fluoroquinolones (GyrA [Ser83Leu, Asp87Asn], ParC [Ser80Ile] and ParE [Ser458Ala]), and resistance determinants to disinfectants and pesticides. Noteworthy, phylogenomic analysis revealed that this multidrug strain clustered with ST90 lineages isolated from human, dog, and livestock in Brazil. The phylogenetic tree also revealed that this strain shares a common ancestor with isolates from the United States, Russia, Germany, and China, highlighting the potential global spreading of this clone. In summary, we report genomic data of CTX-M-15-positive ST90 colonizing a pet. Colonization of companion animals by critical resistant pathogens highlights the need for close monitoring to better understand the epidemiology and genetic factors contributing for successful adaptation of global clones at the human-animal interface.
产超广谱β-内酰胺酶(ESBL)的在全球范围内的传播被认为是“同一健康(One Health)”框架内的一个关键问题。本研究的目的是对从巴西狗的胃肠道中分离出的、属于全球传播的序列型/克隆复合体 ST90/CC23 的产 ESBL 菌株进行基因组研究。除了 CTX-M-15 ESBL 外,该分离株还携带了赋予其对人和兽医氟喹诺酮类药物(GyrA [Ser83Leu、Asp87Asn]、ParC [Ser80Ile] 和 ParE [Ser458Ala])耐药的突变以及对消毒剂和杀虫剂的耐药决定因素。值得注意的是,系统发育基因组分析显示,该多药菌株与从巴西的人、狗和家畜中分离出的 ST90 谱系聚集在一起。该系统发育树还表明,该 菌株与来自美国、俄罗斯、德国和中国的分离株具有共同的祖先,这突显了该克隆在全球传播的潜力。总之,我们报告了 CTX-M-15 阳性 ST90 定植于宠物的基因组数据。伴侣动物定植的耐药性关键病原体突出了需要进行密切监测,以更好地了解在人-动物界面上有助于全球克隆成功适应的流行病学和遗传因素。